# DTIL (Precision Biosciences Inc.) - SEC EDGAR Financial Statements

> Precision Biosciences Inc. reported $45.04M in revenue and a net loss of $38.55M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -80.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/DTIL
- Markdown: https://convexityos.com/fundamentals/DTIL.md
- SEC CIK: 0001357874
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:42 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001357874&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $45.04M | -100.0% YoY |
| Operating Income | TTM | -$36.16M | -80.3% margin |
| Net Income | TTM | -$38.55M | -85.6% net margin |
| Diluted EPS | TTM | -$1.41 | Split-adjusted |
| Free Cash Flow | TTM | -$51.80M | -115.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $81.85M | Total debt: $5.29M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $34.26M | $68.70M | $48.73M | $25.10M | $115.5M | $24.29M | $1.07B | $10.88M |
| Research & Development | $54.17M | $59.56M | $53.38M | $46.12M | $115.2M | $98.06M | $82.42M | $45.12M |
| Total Operating Expenses | $86.41M | $94.86M | $92.46M | $87.41M | $154.9M | $134.1M | $109.4M | $58.80M |
| **Operating Income** | -$52.15M | -$26.16M | -$43.74M | -$62.31M | -$39.38M | -$109.8M | -$87.20M | -$47.91M |
| **EBITDA** | -$50.68M | -$22.76M | -$36.92M | -$54.51M | -$30.39M | -$101.1M | -$81.89M | -$45.56M |
| Interest Income | $4.24M | $6.76M | $7.69M | $3.47M | $208K | $822K | $4.27M | $1.88M |
| Interest Expense | $1.42M | $1.78M | $2.23M | $1.11M | $132K | -- | $182K | -- |
| Income Before Tax | -$45.72M | $7.17M | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- | -- | $23K | -- | -- |
| **Net Income** | -$45.72M | $7.17M | -$61.32M | -$111.6M | -$30.60M | -$109.0M | -$92.88M | -$46.04M |
| Basic EPS | -$3.56 | $1.05 | -$15.96 | -$1.27 | -$0.52 | -$2.09 | -$2.21 | -$2.92 |
| **Diluted EPS** | -$3.56 | $1.04 | -$15.96 | -$1.27 | -$0.52 | -$2.09 | -$2.21 | -$2.92 |
| Basic Shares Outstanding | 12.8M | 6.8M | 3.8M | 87.9M | 58.6M | 52.0M | 41.9M | 15.8M |
| Diluted Shares Outstanding | 12.8M | 6.9M | 3.8M | 87.9M | 58.6M | 52.0M | 41.9M | 15.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $10.84M | $34.20M | $13K | $18K | $29K | $638K |
| Research & Development | $12.74M | $12.39M | $13.11M | $14.46M | $13.35M | $12.77M | $13.59M | $15.91M |
| Total Operating Expenses | $20.43M | $19.16M | $19.91M | $21.70M | $20.68M | $21.89M | $22.14M | $25.48M |
| **Operating Income** | -$20.43M | -$19.16M | -$9.07M | $12.51M | -$20.67M | -$21.88M | -$22.11M | -$24.85M |
| **EBITDA** | -$20.21M | -$18.91M | -$8.78M | $12.85M | -$20.32M | -$21.50M | -$21.72M | -$24.39M |
| Interest Income | $881K | $943K | $999K | $773K | $1.03M | $1.12M | $1.32M | $1.49M |
| Interest Expense | $307K | $300K | $311K | $348K | $362K | $358K | $354K | $392K |
| **Net Income** | -$7.59M | -$32.65M | -$18.44M | $20.13M | -$21.77M | -$23.52M | -$20.57M | -$17.75M |
| Basic EPS | -$0.28 | -$1.26 | -$0.75 | -- | -$1.84 | -$2.13 | -$2.21 | -- |
| **Diluted EPS** | -$0.28 | -$1.26 | -$0.75 | -- | -$1.84 | -$2.13 | -$2.21 | -- |
| Basic Shares Outstanding | 27.4M | 25.9M | 24.6M | -- | 11.8M | 11.0M | 9.3M | -- |
| Diluted Shares Outstanding | 27.4M | 25.9M | 24.6M | -- | 11.8M | 11.0M | 9.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $110.8M | $85.90M | $116.7M | $189.6M | $143.7M | $89.80M | $180.9M | $103.2M |
| Short-Term Investments | $4.76M | $413K | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $115.6M | $86.31M | $116.7M | $189.6M | $143.7M | $89.80M | $180.9M | $103.2M |
| Accounts Receivable, Net | $0 | $229K | $901K | $720K | $488K | $10.00M | $965K | $523K |
| Other Current Assets | $45K | $369K | $419K | $1.23M | $169K | $4.0K | $2.32M | $3.05M |
| **Total Current Assets** | $118.7M | $94.99M | $136.4M | $199.1M | $161.8M | $105.6M | $193.7M | $115.7M |
| Property, Plant & Equipment, Net | $1.43M | $3.09M | $6.34M | $11.81M | $25.15M | $35.09M | $39.57M | $21.15M |
| Intangible Assets | $1.17M | $622K | $400K | $731K | $2.05M | $1.37M | $1.43M | $1.47M |
| Other Non-Current Assets | $206K | $221K | $225K | $226K | $4.64M | $1.72M | $558K | $312K |
| **Total Non-Current Assets** | $35.68M | $41.40M | $23.42M | $39.06M | $49.74M | $44.59M | $41.56M | $22.93M |
| **Total Assets** | $154.4M | $136.4M | $159.8M | $238.2M | $211.5M | $150.2M | $235.2M | $138.6M |
| Accounts Payable | $296K | $1.31M | $2.97M | $653K | $1.14M | $792K | $2.04M | $2.22M |
| Deferred Revenue (Current) | $0 | $2.96M | $12.04M | $46.19M | $21.24M | $30.24M | $16.49M | $8.44M |
| Other Current Liabilities | $649K | $989K | $2.39M | $745K | $977K | $854K | $1.58M | -- |
| **Total Current Liabilities** | $8.91M | $14.98M | $49.99M | $59.66M | $35.98M | $42.83M | $26.93M | $14.07M |
| Long-Term Debt | -- | -- | -- | $22.22M | $2.48M | -- | -- | -- |
| Deferred Revenue (Non-Current) | $0 | $23.30M | $73.08M | $82.87M | $67.02M | $53.93M | $65.89M | $82.81M |
| Other Non-Current Liabilities | $259K | $194K | $128K | $201K | $44K | $392K | -- | -- |
| **Total Non-Current Liabilities** | $53.26M | $65.02M | $90.93M | $118.1M | $84.35M | $62.90M | $69.99M | $84.56M |
| **Total Liabilities** | $62.17M | $80.00M | $140.9M | $177.7M | $120.3M | $105.7M | $96.92M | $98.64M |
| **Total Debt (incl. Leases)** | $6.40M | $7.72M | $8.86M | $27.04M | $9.11M | $10.52M | -- | -- |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | -- | -- | -- | -- |
| Retained Earnings | -$528.2M | -$482.5M | -$489.6M | -$428.3M | -$316.7M | -$286.1M | -$177.1M | -$85.19M |
| **Total Stockholders' Equity** | $92.25M | $56.39M | $18.86M | $60.43M | $91.17M | $44.42M | $138.3M | $39.96M |
| Total Equity | $92.25M | $56.39M | $18.86M | $60.43M | $91.17M | $44.42M | $138.3M | $39.96M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $81.70M | $86.08M | $99.37M | $110.8M | $44.87M | $62.24M | $77.22M | $85.90M |
| Short-Term Investments | $148K | $1.47M | $1.81M | $4.76M | $0 | $0 | -- | $413K |
| **Cash & Short-Term Investments** | $81.85M | $87.55M | $101.2M | $115.6M | $44.87M | $62.24M | $77.22M | $86.31M |
| Accounts Receivable, Net | $0 | $0 | $4.00M | $0 | $4.0K | $0 | $4.0K | $229K |
| Other Current Assets | $5.0K | $5.0K | $6.0K | $45K | $848K | $427K | $116K | $369K |
| **Total Current Assets** | $86.58M | $91.55M | $108.7M | $118.7M | $51.70M | $70.26M | $82.10M | $94.99M |
| Property, Plant & Equipment, Net | $779K | $964K | $1.18M | $1.43M | $2.03M | $2.36M | $2.72M | $3.09M |
| Intangible Assets | $1.06M | $1.09M | $1.13M | $1.17M | $985K | $605K | $607K | $622K |
| Other Non-Current Assets | $124K | $126K | $203K | $206K | $200K | $208K | $215K | $221K |
| **Total Non-Current Assets** | $33.80M | $34.37M | $35.20M | $35.68M | $41.80M | $38.67M | $42.31M | $41.40M |
| **Total Assets** | $120.4M | $125.9M | $143.9M | $154.4M | $93.51M | $108.9M | $124.4M | $136.4M |
| Accounts Payable | $813K | $828K | $944K | $296K | $1.34M | $1.12M | $924K | $1.31M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $6.25M | $5.99M | $5.73M | $2.96M |
| Other Current Liabilities | $527K | $588K | $858K | $649K | $611K | $721K | $896K | $989K |
| **Total Current Liabilities** | $8.27M | $7.14M | $7.75M | $8.91M | $15.00M | $13.57M | $12.39M | $14.98M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $19.96M | $20.23M | $20.50M | $23.30M |
| Other Non-Current Liabilities | $302K | $301K | $324K | $259K | $227K | $200K | $197K | $194K |
| **Total Non-Current Liabilities** | $60.33M | $73.49M | $60.03M | $53.26M | $61.88M | $61.31M | $62.68M | $65.02M |
| **Total Liabilities** | $68.60M | $80.63M | $67.79M | $62.17M | $76.88M | $74.87M | $75.07M | $80.00M |
| **Total Debt (incl. Leases)** | $5.29M | $5.68M | $6.05M | $6.40M | $6.75M | $7.09M | $7.41M | $7.72M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$586.9M | -$579.3M | -$546.6M | -$528.2M | -$548.3M | -$526.5M | -$503.0M | -$482.5M |
| **Total Stockholders' Equity** | $51.77M | $45.29M | $76.10M | $92.25M | $16.63M | $34.05M | $49.34M | $56.39M |
| Total Equity | $51.77M | $45.29M | $76.10M | $92.25M | $16.63M | $34.05M | $49.34M | $56.39M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.72M | $7.17M | -$61.32M | -$111.6M | -$30.60M | -$109.0M | -$92.88M | -$46.04M |
| Depreciation & Amortization | $1.47M | $3.40M | $6.82M | $7.80M | $8.98M | $8.78M | $5.32M | $2.35M |
| Stock-Based Compensation | $10.19M | $12.60M | $14.04M | $19.20M | $16.51M | $13.79M | $8.94M | $2.45M |
| Change in Receivables | $229K | $672K | -$181K | -$232K | $9.51M | -$9.04M | -$441K | -$523K |
| Change in Payables | -$737K | -$2.10M | $1.51M | $153K | $867K | -$1.46M | $667K | -$673K |
| **Operating Cash Flow** | -$65.84M | -$58.45M | -$84.11M | -$45.75M | -$10.85M | -$87.39M | -$71.02M | -$51.72M |
| Capital Expenditure | -$85K | -$250K | -$1.96M | -$3.32M | -$5.05M | -$5.03M | -$24.67M | -$14.28M |
| **Free Cash Flow** | -$65.93M | -$58.70M | -$86.07M | -$49.07M | -$15.91M | -$92.42M | -$95.68M | -$66.00M |
| **Investing Cash Flow** | -$634K | -$215K | $5.83M | -$3.32M | -$5.80M | -$5.03M | -$24.67M | -$15.66M |
| Common Stock Issued | -- | -- | $4.99M | $49.34M | $25.48M | -- | -- | -- |
| **Financing Cash Flow** | $95.16M | $50.45M | $5.39M | $94.98M | $70.52M | $1.33M | $173.4M | $107.8M |
| **Net Change in Cash** | $28.68M | -$8.21M | -$72.90M | $45.91M | $53.87M | -$91.09M | $77.69M | $40.39M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.59M | -$32.65M | -$18.44M | $20.13M | -$21.77M | -$23.52M | -$20.57M | -$17.75M |
| Depreciation & Amortization | $222K | $253K | $299K | $345K | $350K | $378K | $395K | $454K |
| Stock-Based Compensation | $2.96M | $1.84M | $1.55M | $2.04M | $2.39M | $2.94M | $2.82M | $3.57M |
| Change in Receivables | $0 | $4.00M | -$4.00M | $4.0K | -$4.0K | $4.0K | $225K | -$41K |
| Change in Payables | -$29K | -$122K | $648K | -$1.05M | $220K | $199K | -$106K | $72K |
| **Operating Cash Flow** | -$15.13M | -$13.44M | -$11.94M | -$11.25M | -$15.27M | -$20.27M | -$19.05M | -$18.68M |
| Capital Expenditure | $0 | $0 | -$18K | -$19K | $0 | -$2.0K | -$64K | -$97K |
| **Free Cash Flow** | -$15.13M | -$13.44M | -$11.96M | -$11.27M | -$15.27M | -$20.27M | -$19.12M | -$18.78M |
| **Investing Cash Flow** | -$200K | $1.0K | -$114K | -$325K | $17K | -$12K | -$314K | -$97K |
| **Financing Cash Flow** | $10.96M | $0 | $745K | $77.52M | $1.66M | $5.30M | $10.69M | $5.92M |
| **Net Change in Cash** | -$4.37M | -$13.44M | -$11.31M | $65.94M | -$13.59M | -$14.98M | -$8.68M | -$12.86M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -152.2% | -38.1% | -89.8% | -248.3% | -34.1% | -452.2% | -8.1% | -440.2% |
| **Net Profit Margin** | -133.4% | 10.4% | -125.8% | -444.8% | -26.5% | -448.9% | -8.7% | -423.0% |
| Return on Equity (ROE) | -49.6% | 12.7% | -325.1% | -184.7% | -33.6% | -245.4% | -67.1% | -115.2% |
| Return on Assets (ROA) | -29.6% | 5.3% | -38.4% | -46.9% | -14.5% | -72.6% | -39.5% | -33.2% |
| Current Ratio | 13.32x | 6.34x | 2.73x | 3.34x | 4.50x | 2.46x | 7.19x | 8.22x |
| Quick Ratio | 12.97x | 5.78x | 2.35x | 3.19x | 4.01x | 2.33x | 6.75x | 7.37x |
| Debt to Equity | 0.07x | 0.14x | 0.47x | 0.45x | 0.10x | 0.24x | -- | -- |
| **Revenue Growth (YoY)** | -50.1% | +41.0% | +94.1% | -78.3% | +375.7% | -97.7% | +9731.8% | -- |
| **Net Income Growth (YoY)** | -738.0% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -439.0% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +471.8% | -60.6% | +1736.9% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -80.3% | -80.8% | -86.8% | -152.2% | -12822.6% | -7145.9% | -86.2% | -38.1% |
| **Net Profit Margin** | -85.6% | -117.0% | -96.7% | -133.4% | -11977.4% | -6205.8% | -43.0% | 10.4% |
| Return on Equity (ROE) | -74.4% | -116.4% | -57.3% | -49.6% | -502.6% | -229.8% | -44.6% | 12.7% |
| Return on Assets (ROA) | -32.0% | -41.9% | -30.3% | -29.6% | -89.4% | -71.8% | -17.7% | 5.3% |
| Current Ratio | 10.47x | 12.82x | 14.02x | 13.32x | 3.45x | 5.18x | 6.62x | 6.34x |
| Quick Ratio | 9.90x | 12.26x | 13.56x | 12.97x | 2.99x | 4.59x | 6.23x | 5.78x |
| Debt to Equity | 0.10x | 0.13x | 0.08x | 0.07x | 0.41x | 0.21x | 0.15x | 0.14x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | +37272.4% | +5261.1% | -97.7% | -100.0% | -99.8% | -90.9% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -190.6% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -171.8% | -339.5% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -145.3% | -230.0% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
